Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 1/20 | 0.55 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.55 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.55 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.55 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.55 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.55 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.55 |
| ▸ | BACE1 | P56817 | 2/20 | 0.52 |
| ▸ | PTH1R | Q03431 | 5/20 | 0.45 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.43 |
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 3/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31285037 | 0.86 | GRIN2D (0.60) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL25083892 | 0.86 | BACE1 (0.49) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL31554828 | 0.85 | GRIN2D (0.49) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL30785131 | 0.85 | GRIN2D (0.60) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL30512767 | 0.85 | BACE1 (0.53) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL29777824 | 0.84 | GRIN2D (0.60) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL5146835 | 0.84 | GRIN2D (0.59) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL29372015 | 0.84 | GRIN2D (0.59) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL31563685 | 0.84 | GRIN2D (0.59) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL24725397 | 0.84 | BACE1 (0.52) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636283-B2 | Inhibition of PRC2 subunits to treat eye disorders | FONDATION ASILE DES AVEUGLES (CH) | 2026-05-26 | — | — | US | disclosed |
| EP-4716688-A1 | STABILIZED HEMAGGLUTININ (HA) TRIMERS AS INFLUENZA VACCINE ANTIGENS | The Scripps Research Institute (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4582540-A1 | METHOD FOR PRODUCING NUCLEIC ACID MOLECULE | Genedesign, Inc. (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-120202295-A | Method for producing nucleic acid molecule | 基因设计有限公司 | 2025-06-24 | — | — | CN | disclosed |
| EP-4543452-A1 | TREATMENT REGIMEN FOR AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES | Merck Patent GmbH (DE) | 2025-04-30 | — | — | EP | disclosed |
| CN-116762959-B | Lactobacillus paracasei microcapsule and preparation method and application thereof | 青岛蔚蓝生物股份有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-3636803-B1 | METHOD FOR PRODUCING HIGH-PURITY ELECTROLYTIC COPPER | MITSUBISHI MATERIALS CORP (JP) | 2025-02-19 | — | — | EP | disclosed |
| WO-2024243249-A1 | STABILIZED HEMAGGLUTININ (HA) TRIMERS AS INFLUENZA VACCINE ANTIGENS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-11-28 | — | — | WO | disclosed |
| US-20240253050-A1 | MICROCHIP HIGH DENSITY HANGING DROP THREE-DIMENSION CULTURE PLATFORM | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2024-08-01 | — | — | US | disclosed |
| CN-116463052-B | Organosilicon anticorrosive paint | 武汉鼎业安环科技集团有限公司 | 2024-07-16 | — | — | CN | disclosed |
| WO-2023247774-A1 | TREATMENT REGIMEN FOR AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES | MERCK PATENT GMBH (DE) | 2023-12-28 | — | — | WO | disclosed |
| US-11845084-B2 | Microchip high density hanging drop three-dimension culture platform | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-12-19 | — | — | US | disclosed |
| CN-116769629-A | Lactobacillus paracasei with intestinal immune disorder symptom regulating function and application thereof | 青岛蔚蓝生物股份有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-116762959-A | Lactobacillus paracasei microcapsule and preparation method and application thereof | 青岛蔚蓝生物股份有限公司 | 2023-09-19 | — | — | CN | disclosed |
| WO-2023168808-A1 | LACTOBACILLUS PARACASEI CAPABLE OF REGULATING SYMPTOMS OF INTESTINAL IMMUNE DISORDERS AND USE THEREOF | 青岛蔚蓝生物股份有限公司 | 2023-09-14 | — | — | WO | disclosed |
| US-11753733-B2 | Method for producing high-purity electrolytic copper | MITSUBISHI MATERIALS CORPORATION (JP) | 2023-09-12 | — | — | US | disclosed |
| CN-116463052-A | Organosilicon anticorrosive paint | 武汉鼎业安环科技集团有限公司 | 2023-07-21 | — | — | CN | disclosed |
| EP-4146172-A1 | NICLOSAMIDE FORMULATIONS AND METHODS OF USE | NeuroBo Pharmaceuticals, Inc. (US) | 2023-03-15 | — | — | EP | disclosed |
| CN-114621888-A | Lactobacillus casei with intestinal immunity disorder regulation function and application thereof | 青岛蔚蓝生物股份有限公司 | 2022-06-14 | — | — | CN | disclosed |
| US-20220074719-A1 | ASYMMETRIC INITIATED SHAPED CHARGE AND METHOD FOR MAKING A SLOT-LIKE PERFORATION | WELLS FARGO BANK, NATIONAL ASSOCIATION | 2022-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636283-B2 | Inhibition of PRC2 subunits to treat eye disorders | EZH2, EZH1, EED | GRIN2D 1033/4885GRIN3B 1759/4885GRIN1 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.